ctrl K

Watchlist Price Alert

OnKure Therapeutics Inc. (OKUR)

NASDAQ: OKUR · Real-Time Price · USD

1.89

-0.11 (-5.50%)

At close: May 09, 2025, 3:59 PM

1.92

1.59%

After-hours: May 09, 2025, 04:05 PM EDT

OnKure Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	50K	37K
Gross Profit	n/a	n/a	n/a	-50K	-37K
Operating Income	-54.39M	-36.93M	-29.77M	-39.82M	-19.55M
Interest Income	2.01M	1.62M	254K	n/a	n/a
Pretax Income	-52.67M	-35.31M	-29.51M	-39.77M	-19.46M
Net Income	-52.67M	-35.31M	-29.51M	-39.77M	-19.46M
Selling & General & Admin	10.59M	4.82M	3.9M	11.65M	3.61M
Research & Development	43.8M	32.12M	25.86M	28.12M	15.91M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	54.39M	36.93M	29.77M	39.77M	19.52M
Interest Expense	300K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	54.39M	36.93M	29.77M	-39.82M	-19.55M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	13.34M	13.34M	13.34M	1.81M	2.51M
Shares Outstanding (Diluted)	13.34M	13.34M	13.34M	1.81M	2.51M
EPS (Basic)	-3.95	-2.65	-2.21	-21.92	-7.74
EPS (Diluted)	-3.95	-2.65	-2.21	-21.92	-7.74
EBITDA	-51.71M	-34.75M	-29.38M	-39.72M	-19.43M
EBIT	-52.37M	-35.31M	-29.77M	-39.77M	-19.46M
Depreciation & Amortization	662K	560K	387K	50K	37K